High-dose intravenous administration of prostaglandin E 2  and F 2   for the termination of midtrimester pregnancies.
D000032:Abortion, Therapeutic; D000293:Adolescent; D000328:Adult; D001794:Blood Pressure; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D005865:Gestational Age; D006801:Humans; D007275:Injections, Intravenous; D007659:Ketones / Q000652:urine; D007964:Leukocytosis / Q000139:chemically induced; D009119:Muscle Contraction; D011247:Pregnancy; D011312:Pressure; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects; D011674:Pulse; D013610:Tachycardia / Q000139:chemically induced; D013997:Time Factors; D014599:Uterus / Q000502:physiology; D014839:Vomiting / Q000139:chemically induced
D007659:Ketones; D011453:Prostaglandins